This observational study included 231 patients from 6 sites who presented chronic total occlusions and underwent rechanneling procedures using currently available techniques, which were successful in 90% of all cases (210 patients). All patients who underwent successful rechanneling received a SYNERGY stent and most of them underwent intravascular ultrasound (90.5%). There was only 1 patient lost to clinical follow-up at one year, while 188 underwent additional follow-up by angiography.
The primary endpoint, target-vessel failure, occurred in 5.2% of patients, while 10% experienced major adverse cardiac events (MACE). Diabetes was the main predictor for MACE (p = 0.004).
Upon analysis, more complex lesions approached through dissection and reentry, which required longer stents, were associated with higher rates of target-vessel revascularization (10% vs. 3.7%; p = 0.042). Rechanneling success was associated to substantial improvement in quality of life at 12 months.
Original title: The Consistent CTO Study -Conventional Antegrade Versus Sub-Intimal SYNERGY Stenting in Chronic Total Occlusions.
Presenter: Simon Walsh.
Get the latest scientific articles on interventional cardiologySubscribe to our weekly newsletter
We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.
